Answer
Ezetimibe is indicated to reduce cardiovascular event risk in patients with coronary heart disease and a history of acute coronary syndrome, when added to ongoing statin therapy or started concomitantly with a statin.
Sources for this answer
- Ezetimibe 10 mg TabletsGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 4Document updated
Sources checked